Europace Advance Access published online on June 23, 2009
Europace, doi:10.1093/europace/eup157
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SHORT COMMUNICATION
Defibrillation testing in patients with atrial fibrillation
University Department of Medicine, City Hospital, Birmingham B18 7QH, UK
Abstract
Implantable cardioverter defibrillator implantation in patients with atrial fibrillation (AF) is complicated by the need for anticoagulation during defibrillation testing. In this retrospective study, we evaluated the factors associated with successful cardioversion of AF during ventricular defibrillation testing and the safety of our local anticoagulation protocol.
* Corresponding author. Tel: +44 121 507 5080, Email: hsern{at}doctors.net.uk
Manuscript submitted 7 March 2009. Accepted after revision 22 May 2009.